MGO ONE SEVEN 13F Shows New LLY Stake, Boosts NVDA Position

Investment management firm MGO ONE SEVEN LLC disclosed its latest portfolio holdings in a Form 13F filing made public on May 14, 2026. The report, which covers the quarter ending March 31, 2026, reveals significant adjustments in the firm's equity positions. Key changes include the initiation of a new $45 million position in pharmaceutical giant Eli Lilly and a substantial increase in its holdings of NVIDIA, signaling a bullish stance on technology and healthcare sectors.

What Are MGO ONE SEVEN's Top Portfolio Changes?

The firm's quarterly filing detailed several key shifts in its investment strategy. The most prominent move was the acquisition of approximately 75,000 shares of Eli Lilly (LLY), establishing a new position valued at $45 million as of the reporting date. This entry into a major healthcare name suggests a strategic allocation towards a sector with strong long-term demographic tailwinds.

Simultaneously, MGO ONE SEVEN increased its exposure to the semiconductor industry by adding 150,000 shares to its NVIDIA (NVDA) position. This purchase brought its total holdings in the chipmaker to over $120 million, making it one of the fund's top five positions. The move reinforces a conviction in the continued growth of artificial intelligence and high-performance computing markets.

In a move indicating a portfolio rebalancing, the firm reduced its stake in consumer staples. The filing showed a sale of 200,000 shares of Procter & Gamble (PG), decreasing the total value of that holding by nearly $32 million. This reduction suggests a pivot away from defensive stocks toward sectors with higher growth potential.

How Does the Filing Reflect Broader Tech Sector Confidence?

MGO ONE SEVEN's decision to increase its NVIDIA stake aligns with a broader trend among institutional investors. Many funds have been increasing their allocation to companies central to the artificial intelligence (AI) buildout. With NVIDIA controlling an estimated 80% of the market for AI accelerator chips, it remains a primary vehicle for capturing growth in the sector.

The increased investment is not just a bet on one company but on the entire AI ecosystem. Firms are positioning for sustained demand from cloud providers, enterprise software companies, and sovereign nations building out their own AI infrastructure. This confidence is supported by strong earnings reports and upward revenue guidance from key tech sector players throughout early 2026.

Why Did the Firm Reduce Consumer Staples Exposure?

The reduction in Procter & Gamble shares points to a classic portfolio rotation. Consumer staples are often favored during periods of economic uncertainty for their stable demand and reliable dividends. Trimming a position in a company like P&G can indicate that a fund manager anticipates a more favorable economic environment where growth stocks are expected to outperform defensive assets.

This strategic shift frees up capital to be deployed into sectors like technology and specialized healthcare, which offer higher return potential, albeit with greater volatility. The firm may be signaling its belief that inflation has peaked and that consumer spending will remain strong, reducing the need for defensive holdings. The value of the shares sold represented approximately 15% of the firm's prior position in the consumer goods company.

What Are the Limitations of 13F Filing Data?

While 13F filings provide valuable insights into the positioning of large investment managers, they come with significant limitations. The most critical drawback is the time lag. The data released on May 14 reflects positions held on March 31, meaning the information is at least 45 days old. A fund's portfolio could have changed substantially in the intervening period.

these filings only disclose long positions in U.S.-listed equities, options, and convertible bonds. They do not reveal short positions, cash holdings, or investments in international markets, commodities, or bonds. This provides an incomplete picture of a firm's overall strategy and risk exposure. Therefore, using 13F filings as the sole basis for an investment decision is not advisable.

Q: What is a Form 13F?

A: A Form 13F is a quarterly report required by the U.S. Securities and Exchange Commission (SEC) for institutional investment managers with at least $100 million in assets under management. The form discloses their U.S. equity holdings to the public. It is intended to increase transparency in the financial markets by showing what major investors are buying and selling over a given quarter, providing a snapshot of institutional sentiment and positioning.

Q: Does a 13F show a firm's entire portfolio?

A: No, a 13F report provides only a partial view. It does not include short positions (bets that a stock will fall), holdings in non-U.S. securities, commodities, currencies, or cash reserves. For example, a fund could hold a large long position in a stock shown on the 13F while simultaneously holding a short position against it via derivatives, a fact that would not be visible. This makes it an incomplete tool for assessing a manager's full conviction or risk profile.

Q: Who is MGO ONE SEVEN LLC?

A: MGO ONE SEVEN LLC is an institutional investment management firm that provides advisory services, primarily to high-net-worth individuals and other institutional clients. As a registered investment advisor, it is required to file Form 13F due to the size of its equity portfolio, which exceeds the $100 million regulatory threshold. The firm employs various strategies, including long/short equity and global macro, to manage its client assets.

Bottom Line

MGO ONE SEVEN's latest 13F filing shows a clear strategic rotation into high-growth technology and healthcare sectors, funded by a reduction in defensive consumer staples.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.